Summary
9.71 0.33(3.52%)05/14/2024
Canopy Growth Corporation (CGC)
Canopy Growth Corporation (CGC)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| -2.44 | -36.29 | -6.64 | 119.04 | 1,510.90 | 616.85 | -80.10 | 186.74 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 9.46 | |
| Open | 9.70 | |
| High | 10.31 | |
| Low | 9.35 | |
| Volume | 12,388,600 | |
| Change | -0.24 | |
| Change % | -2.44 | |
| Avg Volume (20 Days) | 19,829,818 | |
| Volume/Avg Volume (20 Days) Ratio | 0.62 | |
| 52 Week Range | 0.35 - 14.92 | |
| Price vs 52 Week High | -36.58% | |
| Price vs 52 Week Low | 2,603.54% | |
| Range | -2.45 | |
| Gap Up/Down | -1.21 | |
Fundamentals | ||
| Market Capitalization (Mln) | 884 | |
| EBIDTA | 0 | |
| PE Ratio | 0.0000 | |
| PEG Ratio | 0.0000 | |
| WallStreet Target Price | 13.49 | |
| Book Value | 10.7790 | |
| Earnings Per Share | -2.6990 | |
| EPS Estimate Current Quarter | -0.1600 | |
| EPS Estimate Next Quarter | -0.1700 | |
| EPS Estimate Current Year | 0.0000 | |
| EPS Estimate Next Year | 0.0000 | |
| Diluted EPS (TTM) | -2.6990 | |
| Revenues | ||
| Profit Marging | -2.1511 | |
| Operating Marging (TTM) | -1.0743 | |
| Return on asset (TTM) | -0.0584 | |
| Return on equity (TTM) | -0.2265 | |
| Revenue TTM | 568,550,016 | |
| Revenue per share TTM | 1.4880 | |
| Quarterly Revenue Growth (YOY) | -0.0290 | |
| Quarterly Earnings Growth (YOY) | 0.0000 | |
| Gross Profit (TTM) | 92,945,000 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 0.0000 | |
| Forward PE | 0.0000 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 1.1231 | |
| Revenue Enterprise Value | 6.2426 | |
| EBITDA Enterprise Value | 0.0000 | |
| Shares | ||
| Shares Outstanding | 393,712,992 | |
| Shares Float | 251,313,607 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 36.24 | |
| Institutions (%) | 17.11 | |
05/14 09:30 EST - MarijuanaStocks
May 2024 Watchlist: Top Canadian Cannabis Stocks Heating Up the Market
As we explore the bustling Canadian cannabis market, several marijuana stocks stand out this week, warranting a closer look. These companies, thriving amid a globally expanding industry, have shown resilience and innovation. Recent statistics reveal the global cannabis market could reach USD 197.74 billion by 2028, according to Grand View Research. This forecast underscores significant growth potential, driven by increasing legalization and medical usage.
May 2024 Watchlist: Top Canadian Cannabis Stocks Heating Up the Market
As we explore the bustling Canadian cannabis market, several marijuana stocks stand out this week, warranting a closer look. These companies, thriving amid a globally expanding industry, have shown resilience and innovation. Recent statistics reveal the global cannabis market could reach USD 197.74 billion by 2028, according to Grand View Research. This forecast underscores significant growth potential, driven by increasing legalization and medical usage.
05/11 11:15 EST - The Motley Fool
The Biden Administration Plans to Reschedule Marijuana: 3 Things You Need to Know Before Rushing to Buy Tilray Brands and Canopy Growth Stock
The Biden Administration is planning to reschedule marijuana, which would be a huge move for the industry. But that doesn't mean that legalization is inevitable.
The Biden Administration Plans to Reschedule Marijuana: 3 Things You Need to Know Before Rushing to Buy Tilray Brands and Canopy Growth Stock
The Biden Administration is planning to reschedule marijuana, which would be a huge move for the industry. But that doesn't mean that legalization is inevitable.
05/11 09:17 EST - MarijuanaStocks
This Is How Marijuana Stocks Will Be Impacted By Reform In 2024
As the cannabis industry continues its growth in 2024, a confluence of regulatory, demographic, and market trends is shaping the sector. This has presented a fertile ground for savvy investors. Here's a deeper look into the evolving landscape of cannabis investments. This year could mark a significant turning point with the potential rescheduling of cannabis at the federal level. If cannabis can one day be federally legal it would be the biggest win for the industry.
This Is How Marijuana Stocks Will Be Impacted By Reform In 2024
As the cannabis industry continues its growth in 2024, a confluence of regulatory, demographic, and market trends is shaping the sector. This has presented a fertile ground for savvy investors. Here's a deeper look into the evolving landscape of cannabis investments. This year could mark a significant turning point with the potential rescheduling of cannabis at the federal level. If cannabis can one day be federally legal it would be the biggest win for the industry.
05/10 09:04 EST - MarijuanaStocks
Ready To Invest? Here Are 3 Top Marijuana Stocks For You
What will happen to marijuana stocks if cannabis does not get rescheduled? Some see this as a possibility and investors want to be prepared. With all the recent talks of cannabis being dropped from a scheduled 1 to a class 3 substance it has led to a rise in trading. The speculation of what's next to come is also feeding into momentum pouring into the sector.
Ready To Invest? Here Are 3 Top Marijuana Stocks For You
What will happen to marijuana stocks if cannabis does not get rescheduled? Some see this as a possibility and investors want to be prepared. With all the recent talks of cannabis being dropped from a scheduled 1 to a class 3 substance it has led to a rise in trading. The speculation of what's next to come is also feeding into momentum pouring into the sector.
05/10 07:30 EST - InvestorPlace
The 3 Best Cannabis Stocks to Buy in May 2024
Cannabis stocks are back in the spotlight and moving higher on news that the U.S. government is moving to reclassify the recreational drug and ease federal restrictions imposed on it. The Biden administration has taken steps to reclassify cannabis, also known as marijuana, as a Schedule III substance.
The 3 Best Cannabis Stocks to Buy in May 2024
Cannabis stocks are back in the spotlight and moving higher on news that the U.S. government is moving to reclassify the recreational drug and ease federal restrictions imposed on it. The Biden administration has taken steps to reclassify cannabis, also known as marijuana, as a Schedule III substance.
05/09 09:19 EST - InvestorPlace
7 Cannabis Stocks to Buy for a Smoking-Hot 2024
Among the emerging industries that have captured the attention of investors is the cannabis sector. The cannabis industry has experienced remarkable growth, giving rise to a new breed of top cannabis stocks to buy for investments in May.
7 Cannabis Stocks to Buy for a Smoking-Hot 2024
Among the emerging industries that have captured the attention of investors is the cannabis sector. The cannabis industry has experienced remarkable growth, giving rise to a new breed of top cannabis stocks to buy for investments in May.
05/07 11:51 EST - Proactive Investors
Canopy Growth begins expansion into US with Wana Brands and Jetty Extracts acquisitions
Canopy Growth Corporation (TSX:WEED, NYSE:CGC) has confirmed it has exercised its options to acquire American cannabis assets Wana Brands and Jetty Extracts, kicking off its expansion into the US market. This comes after Canopy Growth shareholders in mid-April approved a new exchangeable share structure that will allow it to operate in the US under a US-domiciled holding company called Canopy USA.
Canopy Growth begins expansion into US with Wana Brands and Jetty Extracts acquisitions
Canopy Growth Corporation (TSX:WEED, NYSE:CGC) has confirmed it has exercised its options to acquire American cannabis assets Wana Brands and Jetty Extracts, kicking off its expansion into the US market. This comes after Canopy Growth shareholders in mid-April approved a new exchangeable share structure that will allow it to operate in the US under a US-domiciled holding company called Canopy USA.
05/07 07:45 EST - Market Watch
Canopy Growth exercises options to buy Wana Brands and Jetty Extracts as it moves into the U.S.
Canopy Growth Corp. CGC, -5.08%, the Canadian cannabis company, said Tuesday it would exercise its options to buy two U.S. marijuana companies as part of its effort to allow its Canopy USA unit to “realize compelling financial benefits, including the ability to drive revenue growth, and realize cost synergies.” The deal comes nearly three years after Canopy Growth made an up-front payment of $297.5 million to Wana Brands.
Canopy Growth exercises options to buy Wana Brands and Jetty Extracts as it moves into the U.S.
Canopy Growth Corp. CGC, -5.08%, the Canadian cannabis company, said Tuesday it would exercise its options to buy two U.S. marijuana companies as part of its effort to allow its Canopy USA unit to “realize compelling financial benefits, including the ability to drive revenue growth, and realize cost synergies.” The deal comes nearly three years after Canopy Growth made an up-front payment of $297.5 million to Wana Brands.
05/04 15:00 EST - InvestorPlace
Stock Market Crash Warning: Don't Get Caught Holding These 3 Nasdaq Stocks
Chair of the Federal Reserve, Jerome Powell, has spoken, and Wall Street won't like it. The Fed has decided to hold off on cutting interest rates, citing discouraging developments in the fight against inflation.
Stock Market Crash Warning: Don't Get Caught Holding These 3 Nasdaq Stocks
Chair of the Federal Reserve, Jerome Powell, has spoken, and Wall Street won't like it. The Fed has decided to hold off on cutting interest rates, citing discouraging developments in the fight against inflation.
05/03 23:43 EST - Seeking Alpha
Cannabis Continues Powering To Big Gains With Historic DEA Rescheduling
The proposed rescheduling of cannabis is the biggest step forward for the industry in decades.
Cannabis Continues Powering To Big Gains With Historic DEA Rescheduling
The proposed rescheduling of cannabis is the biggest step forward for the industry in decades.
05/03 19:16 EST - Zacks Investment Research
Canopy Growth Corporation (CGC) Stock Declines While Market Improves: Some Information for Investors
The latest trading day saw Canopy Growth Corporation (CGC) settling at $10.24, representing a -0.97% change from its previous close.
Canopy Growth Corporation (CGC) Stock Declines While Market Improves: Some Information for Investors
The latest trading day saw Canopy Growth Corporation (CGC) settling at $10.24, representing a -0.97% change from its previous close.
05/03 07:01 EST - MarketBeat
Cannabis Stocks: Game-Changing Catalyst for the Sector?
Cannabis stocks reignited Tuesday afternoon after the U.S. Department of Justice announced that it would move to reclassify marijuana as a less dangerous drug. As a result of the breaking news, several leading cannabis stocks, like Tilray NASDAQ: TLRY, Aurora Cannabis NASDAQ: ACB, and Canopy Growth NASDAQ: CGC experienced notable upticks in volume and price, posting impressive double-digit intraday gains before pulling back on Wednesday.
Cannabis Stocks: Game-Changing Catalyst for the Sector?
Cannabis stocks reignited Tuesday afternoon after the U.S. Department of Justice announced that it would move to reclassify marijuana as a less dangerous drug. As a result of the breaking news, several leading cannabis stocks, like Tilray NASDAQ: TLRY, Aurora Cannabis NASDAQ: ACB, and Canopy Growth NASDAQ: CGC experienced notable upticks in volume and price, posting impressive double-digit intraday gains before pulling back on Wednesday.
05/03 06:01 EST - InvestorPlace
Stock Market Crash Warning: Don't Get Caught Holding These 3 Cannabis Stocks
For cannabis stock investors, April ended in absolute euphoria. The sector has skyrocketed this week.
Stock Market Crash Warning: Don't Get Caught Holding These 3 Cannabis Stocks
For cannabis stock investors, April ended in absolute euphoria. The sector has skyrocketed this week.
05/01 15:13 EST - The Motley Fool
Why Canopy Growth, Tilray, and Cronos Group Stocks Just Cratered
The DEA recommended loosening regulations on marijuana yesterday. As a Schedule III drug, marijuana would still be regulated and some costs would rise for cannabis companies -- but others would fall.
Why Canopy Growth, Tilray, and Cronos Group Stocks Just Cratered
The DEA recommended loosening regulations on marijuana yesterday. As a Schedule III drug, marijuana would still be regulated and some costs would rise for cannabis companies -- but others would fall.
05/01 12:11 EST - InvestorPlace
Cannabis Stocks CGC, ACB, TLRY Drop After Huge Rescheduling Rally
Cannabis stocks are falling on Wednesday as shares of marijuana companies are giving up some of the massive gains they saw yesterday. That rally came about after reports claimed the Biden Administration is moving forward with plans to reschedule cannabis from a Schedule I drug to a Schedule III drug.
Cannabis Stocks CGC, ACB, TLRY Drop After Huge Rescheduling Rally
Cannabis stocks are falling on Wednesday as shares of marijuana companies are giving up some of the massive gains they saw yesterday. That rally came about after reports claimed the Biden Administration is moving forward with plans to reschedule cannabis from a Schedule I drug to a Schedule III drug.
05/01 08:43 EST - InvestorPlace
Trade of the Day: Buy Canopy Growth (CGC) Stock Call Options on Rescheduling News
Following a major breakthrough, cannabis operators such as Canopy Growth (NASDAQ: CGC ) saw their shares rise dramatically yesterday. As InvestorPlace's Shrey Dua reported, President Joe Biden's administration is moving to reschedule marijuana as a Schedule III substance.
Trade of the Day: Buy Canopy Growth (CGC) Stock Call Options on Rescheduling News
Following a major breakthrough, cannabis operators such as Canopy Growth (NASDAQ: CGC ) saw their shares rise dramatically yesterday. As InvestorPlace's Shrey Dua reported, President Joe Biden's administration is moving to reschedule marijuana as a Schedule III substance.
04/30 20:49 EST - Market Watch
U.S. poised to ease restrictions on marijuana in historic shift, though it'll remain controlled substance
WASHINGTON — The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, the Associated Press has learned, a historic shift to generations of American drug policy that could have wide ripple effects across the country.
U.S. poised to ease restrictions on marijuana in historic shift, though it'll remain controlled substance
WASHINGTON — The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, the Associated Press has learned, a historic shift to generations of American drug policy that could have wide ripple effects across the country.
04/30 17:41 EST - Skynews
US plans to reclassify cannabis as less dangerous drug
The US is planning to reclassify cannabis as a less dangerous drug in an historic shift that could have a significant impact across the country.
US plans to reclassify cannabis as less dangerous drug
The US is planning to reclassify cannabis as a less dangerous drug in an historic shift that could have a significant impact across the country.
04/30 17:38 EST - Schwab Network
Pot Stocks Rally as DEA Moves to Reclassify Marijuana as Less Dangerous Drug
Pot stocks rally as the DEA moves to reclassify marijuana as a less dangerous drug. Renita Young discusses this as the DEA's proposal needs to be reviewed by the White House Office of Management and Budget.
Pot Stocks Rally as DEA Moves to Reclassify Marijuana as Less Dangerous Drug
Pot stocks rally as the DEA moves to reclassify marijuana as a less dangerous drug. Renita Young discusses this as the DEA's proposal needs to be reviewed by the White House Office of Management and Budget.
04/30 17:04 EST - InvestorPlace
Cannabis Stocks Surge as Biden Moves to Reclassify Marijuana ASAP
Cannabis stocks soared nearly across the board this afternoon on news that President Joe Biden's administration is moving to reschedule marijuana as a Schedule III substance, a less severe designation than its prior Schedule I classification. Indeed, acting on a review from the Department of Health and Human Substances, the U.S. Drug Enforcement Administration (DEA) and U.S. Justice Department may recategorize cannabis as early as this week.
Cannabis Stocks Surge as Biden Moves to Reclassify Marijuana ASAP
Cannabis stocks soared nearly across the board this afternoon on news that President Joe Biden's administration is moving to reschedule marijuana as a Schedule III substance, a less severe designation than its prior Schedule I classification. Indeed, acting on a review from the Department of Health and Human Substances, the U.S. Drug Enforcement Administration (DEA) and U.S. Justice Department may recategorize cannabis as early as this week.